# Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin

> **NCT00338104** · PHASE4 · COMPLETED · sponsor: **Northwestern University** · enrollment: 75 (actual)

## Conditions studied

- Hyperglycemia
- Diabetes

## Interventions

- **DRUG:** insulin glargine
- **DRUG:** insulin glargine
- **DRUG:** insulin glargine

## Key facts

- **NCT ID:** NCT00338104
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2009-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00338104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00338104, "Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00338104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*